Australia's largest stock trading and investment forum Australia's #1 stock forum

ORL

Click for more information

0.00%

43.5¢ orotongroup limited

Exactly right. They poisoned the company and made it very hard...

First 5 Last

Share
Profile

Follow
persistentone

1,486 Posts.

16

22/05/15

11:21

Post #: 15330940
Share

Originally posted by ValueSnatcher ↑

EV/EBIT for ORL is currently around 18x based on guidance and a $2.15 share price.

PMV by comparison at the FY result was 13x.

Making an acquisition tough to justify on current earnings. Also they state that the AUD is a big contributor to the decline, however I don't think many of us would expect the AUD to settle much higher than even 85c at the most optimistic estimates. More likely lower than currently. So this statement, in a way, tells me that they have can expect more downside to earnings as the dollar falls.

There is scope to increase EBIT substantially if any acquierer could steady the ship by getting Oroton back on track and getting the acquisitions in shape.
But I think that the assets are a bit odd for an acquirer to want. You have a high end fashion biz and then two low margin distribution brands..which will require completely different strategy.

Expand

Exactly right. They poisoned the company and made it very hard to sell by buying retailers.

ORL Price at posting: $2.20 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

There are more pages in this discussion • 4 more messages in this thread...

First 5 Last

Add ORL (ASX) to my watchlist